Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 24, 2026
TickeronGET DAILY SIGNALS
CBOE vs CME: Contrasting Paths for Two Exchange Operators

CBOE vs CME: Contrasting Paths for Two Exchange Operators

Key Takeaways

  • Both CBOE and CME are exchange operators that posted record financial results recently, but they derive growth from different product mixes and customer bases.
  • CBOE is skewing toward options, index products, and data under a new CEO, while divesting smaller international businesses to sharpen focus.
  • CME dominates futures and clearing, and is investing in 24/7 crypto trading, event contracts, and a new securities clearinghouse as growth drivers.
  • Analyst sentiment has diverged somewhat: CBOE received a recent upgrade, while CME carries a more mixed rating profile despite record volumes.
  • Relative performance favors different profiles — CBOE leans on higher-margin index and data revenue, while CME offers greater scale and diversification across interest rates, energy, metals, and crypto.
  • For ongoing coverage, explore CBOE Major News and CBOE Today's Price Move, plus CME Major News and CME Today's Price Move.
  • To see how AI approaches this and other comparisons in real time, browse the Trending AI Robots.

Why These Exchange Names Stand Out

Exchange operators tend to generate steady cash flows from trading activity no matter which way markets move. CBOE and CME rank among the most visible players here, yet they focus on different parts of the derivatives and securities landscape. This comparison matters for investors weighing how product focus, innovation, and performance stack up between a broad futures and clearing business and an options-and-index specialist. I also checked this using Tickeron’s AI Screener to see how the two compare within the broader industry group.

CBOE's Strategic Shift

Cboe Global Markets, Inc. (CBOE) runs options, futures, and securities exchanges and is particularly known for its index options such as S&P 500 Index (SPX) options and VIX volatility products. The firm recently posted record quarterly revenue, supported by double-digit growth in options and solid results in derivatives and data. Adjusted earnings per share increased notably year over year thanks to higher volumes and better operating leverage.

Under new leadership the company is streamlining. It plans to exit smaller operations in Australia and Canada, scale back parts of its European derivatives platform, and stop corporate listings work. These steps aim to concentrate resources on core index and options offerings. Barclays recently upgraded CBOE to Overweight, pointing to healthy index-options growth and the clearer strategy. Key risks remain around concentration in flagship products and ongoing fee competition.

CME's Expansion Focus

CME Group Inc. (CME) operates the largest futures exchange, covering interest rates, equities, energy, agriculture, metals, and foreign exchange. It reported its fourth straight year of record annual revenue and adjusted earnings, with quarterly revenue rising on higher clearing and transaction fees. Average daily volume hit new highs, helped by equities, metals, and cryptocurrency products.

Growth initiatives rather than cutbacks are driving the narrative. Management is pushing 24/7 crypto trading, a new securities clearinghouse, and event contracts that have already seen early volume. Crypto-related daily volumes rose sharply and market data revenue reached a record. The firm noted higher 2026 expenses tied to these moves, which analysts balance against its otherwise stable margins. Ratings remain mixed, with one upgrade to Buy offset by neutral stances elsewhere.

Side-by-Side View

The main difference lies in business mix. CME is the larger and more diversified player, with revenue spread across a wide futures and clearing operation and a market capitalization above $100 billion. CBOE is smaller and more focused, with heavy reliance on proprietary index options and data that deliver strong margins but bring product-specific exposure.

Growth approaches also diverge. CBOE is tightening its scope by extending near-24-hour index-options trading and emphasizing high-margin data and index revenue while shedding smaller units. CME is broadening through crypto, event contracts, and clearing infrastructure. Risks follow the strategies: CBOE faces concentration and execution challenges from its restructuring, while CME contends with expense growth and integration of new initiatives. Both delivered record results, though CBOE has shown stronger near-term analyst momentum while CME benefits from scale and steadier performance.

AI-Based Assessment

Looking at trend consistency, catalysts, and positioning, the probabilistic view points to a modest edge for CBOE in the near term. Record earnings, the recent upgrade, and a strategy centered on higher-margin index and options products create a clearer set of near-term drivers compared with CME's longer-term investment programs. That said, CME brings greater stability, diversification, and scale that may suit more risk-averse or extended time horizons. The edge can shift with new volume and earnings data.

AI Tools in Practice

In my own work I have found Tickeron’s AI Trading Bots helpful for monitoring names like these across different market conditions. The platform hosts a range of automated strategies with varying styles, timeframes, and performance histories, allowing users to review which models align best with current trends. Readers can explore the available bots and their statistics directly on the site.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CME, CBOE

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CME saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for CME moved out of overbought territory on November 18, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 68 similar instances where the indicator exited the overbought zone. In 30 of the 68 cases the stock moved lower. This puts the odds of a downward move at 44%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CME moved out of overbought territory on November 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 16 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 40%.

The Moving Average Convergence Divergence Histogram (MACD) for CME turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 19 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 41%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 20, 2026. You may want to consider a long position or call options on CME as a result. In 64 of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.

Following a +1.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in 174 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.

The Aroon Indicator entered an Uptrend today. In 137 of 259 cases where CME Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 31 (best 1 - 100 worst), indicating outstanding price growth. CME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 32 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.147) is normal, around the industry mean (4.143). P/E Ratio (25.814) is within average values for comparable stocks, (19.659). CME's Projected Growth (PEG Ratio) (4.578) is very high in comparison to the industry average of (1.780). Dividend Yield (0.017) settles around the average of (0.017) among similar stocks. CME's P/S Ratio (14.535) is slightly higher than the industry average of (7.166).

Notable companies

The most notable companies in this group are CME Group (NASDAQ:CME).

Industry description

The financial publishing /services sector includes companies that provide informational products and services that are of value to investors, financial/analytics professionals and other interested readers. The products include real-time stock quotes, financial news and analyses. Think S&P Global, Inc., Moody`s Corporation, Thomson-Reuters Corp and IHS Markit Ltd. Information is critical in making financial or investment decisions, and what makes this industry’s output relevant at all times, across various economic conditions.

Market Cap

The average market capitalization across the Financial Publishing/Services Industry is 46.28B. The market cap for tickers in the group ranges from 1.27M to 137.91B. SPGI holds the highest valuation in this group at 137.91B. The lowest valued company is BTOG at 1.27M.

High and low price notable news

The average weekly price growth across all stocks in the Financial Publishing/Services Industry was -7%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 3%. DTCX experienced the highest price growth at 3%, while COIN experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Financial Publishing/Services Industry was 56%. For the same stocks of the Industry, the average monthly volume growth was 10% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 80
P/E Growth Rating: 49
Price Growth Rating: 44
SMR Rating: 52
Profit Risk Rating: 75
Seasonality Score: 30 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of securities and commodity exchanges

Industry FinancialPublishingServices

Industry
Investment Banks Or Brokers
Address
20 South Wacker Drive
Phone
+1 312 930-1000
Employees
3875
Web
https://www.cmegroup.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.